downgrad hold significantli higher top
downgrad hold lower target agre cash
acquisit price proxi rais question snn could come back
bid though model suggest would stretch get snn
result dilut leverag would like trump strateg rational even
possibl upsid justifi buy rate merger model
snn attach
higher bid seem unlik proxi offer interest commentari
higher bid seem low probabl event us file suggest five compani
engag one point anoth snn parti initi interest
fall unexpect ceo departur octob compani note
anyth februari earliest other express interest
part parti think possibl look merger equal parti
think possibl less attract board rel
cash acquisit term possibl bid snn believ
strong strateg rational transact would move compani
growth profil higher financi aspect deal price rang would
lead signific dilut and/or leverag depend deal structur
reach use debt equiti deal would
leav snn lever would dilut ep first year snn
previous note rang comfort snn could
would stretch financi also break fee deeper pocket
would make success top bid messi proposit merger model
snn acquir attach
updat model sale growth ahead
forecast mostli driven out-performance us lower
extrem vs upper extrem vs busi
off-set biolog flat sport med/oth
pt reflect offer price lower price target agre
take-out per share commit sept close includ ampl time
expect ftc review process impli return deal close
annul return even give probabl bid
current upsid result enough justifi
pleas see analyst certif import disclosur inform inform regard statu non-u analyst
page report
acquisit current agre share
pt cash offer price
also ev/sal revenu includ cartiva
higher bid compani materi
pt ev/sal higher bid
acqusit compani occur
share trade valuat reflect underl
pt ev/sal combin pro-forma
hold rate predic compani
acquir per share cash
upsid current price
addit bid compani
announc potenti suitor
progress toward eventu close bid
expect
pleas see import disclosur inform page report
exhibit merger model
pleas see import disclosur inform page report
price allocationamtsaccret ecurr offer per share revenu synergi dis-synergi share outstand equiti valu adjust om ev structureamtscombin pre-tax adjust revenu synergi dis-synergi debt rate share pro-forma adj om current interest interest new adjust annual interest interest pro-forma annual int exp interest cost newli issu exist interest cost post transact debt book valu pre-tax exist tax price adjust ni fix asset share intang cash amort ep accretion/ dilut amort ep accretion/ dilut exist annual amoritz capitalamtssynergi exist synergi dis-synergi exist synergi op use margin exist revenu growth exist revenu growth ebita ebita net dis-synergi ebita ebit net debt ratio ebit debt ratio xsynergi ebitda intang amort exhibit snn merger model
pleas see import disclosur inform page report
price allocationamtsaccret ecurr offer per share revenu synergi dis-synergi share outstand equiti valu mm inc break adjust om ev structureamtscombin pre-tax adjust revenu synergi dis-synergi debt rate share pro-forma adj om current interest interest new adjust annual interest interest pro-forma annual int exp interest cost newli issu exist interest cost post transact debt book valu pre-tax exist tax price adjust ni fix asset share intang pro-forma cash amort ep accretion/ dilut amort ep accretion/ dilut exist annual amoritz capitalamtssynergi esnn exist synergi dis-synergi exist synergi op use margin esnn exist revenu growth exist revenu growth ebita ebita net dis-synergi ebita ebit net debt ratio ebit debt ratio xsynergi ebitda intang amort exhibit incom statement
pleas see import disclosur inform page report
enet intang adjustedtot op expens ex amort expens net expens net incom loss continu oper intang ereport revenueunit stateslow unit state globallow sale continu compani report compani constant currenc compani organ compani pro-forma equiti research
wright medic lead compani global orthoped extrem market
pt use cash offer price also ev/sal revenu includ cartiva risk includ
competit new product launch integr
pt ep line peer risk includ integr oper execut price competit
valuat base dcf upsid risk em slowdown sharper price regulatori intervent
price target ep line med-tech name similar growth profil risk includ price volum
growth competit
price target ep multipl lower end med-tech peer risk includ regulatori competit
raj denhoy certifi view express research report accur reflect person view subject
secur subject compani also certifi part compens directli indirectli relat
specif recommend view express research report
anthoni petron cfa certifi view express research report accur reflect person view
subject secur subject compani also certifi part compens directli indirectli
relat specif recommend view express research report
briana warschun certifi view express research report accur reflect person view subject
secur subject compani also certifi part compens directli indirectli relat
specif recommend view express research report
case jefferi employe analyst respons coverag financi instrument discuss
report receiv compens base part overal perform firm includ invest bank incom seek
updat research appropri variou regul may prevent us asid certain industri report publish
period basi larg major report publish irregular interv appropri analyst judgement
articl articl
raj denhoy hold long equiti posit
jefferi group llc make market secur adr integra life-sci hold corp
jefferi group llc make market secur adr smith nephew
explan jefferi rate
buy describ secur expect provid total return price appreci plu yield within period
pleas see import disclosur inform page report
hold describ secur expect provid total return price appreci plu yield plu minu within
under-perform describ secur expect provid total return price appreci plu yield minu less within
expect total return price appreci plu yield buy rate secur averag secur price consist
within period compani typic volatil overal stock market hold rate
secur averag secur price consist expect total return price appreci plu yield plu minu
within period under-perform rate secur averag secur price consist expect
total return price appreci plu yield minu less within period
nr invest rate price target temporarili suspend suspens complianc applic
cs coverag suspend jefferi suspend coverag compani
nc cover jefferi cover compani
restrict describ issuer conjunct jefferi engag certain transact compani polici applic
secur regul prohibit certain type commun includ invest recommend
monitor describ secur whose compani fundament financi monitor financi project
opinion invest merit compani provid
jefferi methodolog assign rate may includ follow market capit matur growth/valu volatil
expect total return next month price target base sever methodolog may includ
restrict analys market risk growth rate revenu stream discount cash flow dcf ebitda ep cash flow cf free cash
price-to-earnings sum part net asset valu dividend return return equiti roe next month
jefferi franchis pick includ stock select among best stock idea equiti analyst month period
stock select base fundament analysi may take account factor analyst convict differenti
analysi favor risk/reward ratio invest theme jefferi analyst recommend jefferi franchis pick
includ buy rate stock number vari depend analyst recommend inclus stock ad
new opportun aris remov reason inclus chang stock met desir return longer rate
buy and/or trigger stop loss stock day volatil bottom quartil stock continu
stop loss remaind stop franchis pick intend repres recommend portfolio stock
sector base may note believ pick fall within invest style growth valu
risk may imped achiev price target
report prepar gener circul provid invest recommend specif individu investor
financi instrument discuss report may suitabl investor investor must make
invest decis base upon specif invest object financi situat util financi advisor
deem necessari past perform financi instrument recommend report taken indic
guarante futur result price valu incom financi instrument mention report rise well
fall may affect chang econom financi polit factor financi instrument denomin currenc
investor home currenc chang exchang rate may advers affect price valu incom deriv
financi instrument describ report addit investor secur adr whose valu affect
currenc underli secur effect assum currenc risk
compani mention report
pleas see import disclosur inform page report
rate price target histori
raj denhoy hold long equiti posit
rate price target histori integra life-sci hold corp
rate price target histori smith nephew sn/ ln
pleas see import disclosur inform page report
